GFL Ltd

- No specific mentions of current or immediate future fundraising through debt or equity in the call transcript. - Capex of around Rs 100 to Rs 200 Crores has been done for new fluorochemical products, but no reference to funding sources. - Discussions focus on organic growth via capacity utilization and new product commercialization rather than raising funds. - Possibility of monetizing wind farm assets is being explored, which could be a source of capital in the future. - No explicit guidance or plans shared regarding issuing new equity or raising additional debt during the call.

- Gujarat Fluorochemicals has undertaken capex of approximately Rs 100 to Rs 200 Crores so far on new fluorochemical products including specialty polymers and other products expected to come into play by 2019. - Minor capexes related to grade development work have been completed; specialty polymers are in qualification stages and expected to start contributing commercially within 6-8 months from the next quarter. - The strategy involves increasing utilization of TFE monomer beyond current capacity by 2019, substituting higher per tonne TFE contributing items. - Significant bottom-line improvements are anticipated in calendar year 2019 due to these new fluoropolymers and capacity utilization gains. - Plans include moving up the value chain with new value-added fluoropolymers and maximizing capacity utilization over the next 2 years. - Management is exploring options to monetize wind farm assets, which could be valued significantly higher than investments made; updates expected after a quarter.

- New specialty polymers and fluoropolymers are expected to start contributing significantly from the next quarter onwards, with a full impact over 4-8 quarters. - Qualification of specialty polymers is lengthy, but once commercialized, full capacity utilization can be reached quickly. - The company aims to reach near full capacity utilization of new fluoropolymers within the next two years. - Capex of approximately Rs 100-200 Crores is underway for new fluorochemical products, expected to come into play by calendar year 2019. - Strategy focuses on maximizing utilization of TFE monomer beyond current capacity and shifting product mix for higher contribution. - Significant bottom-line improvements are anticipated by calendar year 2019. - PTFE capacity utilization is currently around 60-75%, aiming for 100% in 4-5 quarters. - Value-added product mix is increasing with a potential 2.5-3x increase in EBITDA over two years due to capacity utilization and product addition.

- New speciality polymers and fluoropolymers are expected to start contributing from the next quarter and will pick up substantially over the next 4-8 quarters. - Full capacity utilization of new fluoropolymers is anticipated within 2 years, leading to improved product mix and higher realizations. - Approximately Rs 100-200 Crores capex has been made on new fluorochemicals, with some products expected to commercialize by calendar year 2019. - Strategy aims to increase utilization of TFE monomer and substitute higher per tonne TFE contributing items, leading to improved margins. - By calendar year 2019, significant bottom-line improvement is expected. - At current EBITDA (Rs 300-350 Crores), full capacity utilization along with new plants could increase EBITDA by 2.5 to 3 times over 2 years. - Growth drivers include higher capacity utilization of PTFE, increased value-added product mix, and new fluoropolymer commercialization.

The transcript provided does not explicitly mention the current or expected order book or pending orders for Gujarat Fluorochemicals Limited. However, key points related to business outlook include: - Specialty polymers and new fluoropolymers qualification processes are underway; commercial contributions expected from the next quarter. - Capex of approximately Rs 100-200 Crores invested in new fluorochemical products. - Full capacity utilization of PTFE and new fluoropolymers expected within 4-8 quarters (about 1 to 2 years). - Significant bottom-line improvement anticipated in calendar year 2019 driven by enhanced product mix and capacity utilization. - Growth driven by end-user industries including both pharmaceutical and agriculture sectors for fluoro specialities. - The strategy focuses on increasing utilization of TFE monomer and expanding product portfolio to improve margins. No direct numeric order book figures or pending order values are disclosed in the provided content.